Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis

NCT00883896 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
195
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer